Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taclonex in adolescent psoriasis vulgaris
NCT00817219Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Jul 2009
- Primary completion
- Dec 2011
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Taclonex + Hydrogel Patch in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Jul 2009; status: completed.
02
Drugs
Taclonex + Hydrogel Patch
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00817219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00817219.